Do SSRIs increase the risk of suicide among depressives even if they are taking only placebo? [1]

Psychotherapy and Psychosomatics

Volumn 72, Issue 6, 2003, Pages 357-358

  Rihmer, Zoltán ^a  

^a NATIONAL INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CLOMIPRAMINE; LITHIUM; SEROTONIN UPTAKE INHIBITOR;

CLINICAL TRIAL; DEPRESSION; DRUG USE; GOOD CLINICAL PRACTICE; HUMAN; LETTER; MOOD DISORDER; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZATION; RISK ASSESSMENT; SEDATION; SIDE EFFECT; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); CAUSALITY; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS; RISK; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 0142120687     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073033     Document Type: Letter

References (7)

1. Healy D: Lines of evidence on the risk of suicide with selective serotonine reuptake inhibitors. Psychother Psychosom 2003;72:71-79.
2. Ahrens B, Müller-Oerlinghausen B: Does lithium exert an independent antidsuicidal effect? Pharmacopsychiatry 2001;34:132-136.
3. Isacsson G: Suicide prevention - A medical breakthrough? Acta Psychiatr Scand 2000;102:113-117.
4. Rihmer Z, Belso N, Kalmár S: Antidepressants and suicide prevention in Hungary. Acta Psychiatr Scand 2001;103:238.
5. Rihmer Z: Can better recognition and treatment of depression reduce suicide rates? A brief review. Eur Psychatry 2001;16:406-409.
6. McClure GMG: Changes in suicide in England and Wales, 1960-1997. Br J Psychiatry 2000;176:64-67.
7. Rihmer Z, Belso; N, Kiss K: Strategies for suicide prevention. Curr Opin Psychiatry 2002;15:83-87.